Corsee Sanders has served as Executive Vice President, Development Operations at Juno Therapeutics, Inc. since January 2017. She is responsible for the planning, management, execution, analysis, and reporting of Juno’s clinical trials. Prior to joining Juno, Dr. Sanders was Senior Vice President and Head of Global Clinical Operations and Industry Collaborations at Roche Pharmaceuticals, where she also served as Head of Global Biometrics and Development Innovation. Previously, she worked in a number of senior leadership roles at Genentech, Inc., where she was instrumental in the development of some of Genentech’s most successful products, including Herceptin and Avastin. At Genentech, her responsibilities covered a range of functions, including biostatistics, epidemiology, health economics and outcomes research, data management, medical writing, information technology, and biosample management. Dr. Sanders holds bachelor’s and master’s degrees in statistics from the University of the Philippines, and received a master’s degree and doctorate in statistics from the Wharton School at the University of Pennsylvania.